CellaVision AB (publ) (CLVSF)

Market Cap	309.31M -34.9%
Revenue (ttm)	76.77M -2.3%
Net Income	14.09M -11.9%
EPS	0.59 -11.9%
Shares Out	n/a
PE Ratio	21.96
Forward PE	18.90
Dividend	n/a
Ex-Dividend Date	n/a

Volume	400
Open	15.00
Previous Close	16.14
Day's Range	13.49 - 15.00
52-Week Range	13.49 - 17.30
Beta	0.96
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 17, 2026

About CellaVision AB

CellaVision AB (publ) develops and sells instruments, software, and reagents for blood and body fluids analysis in Sweden and internationally. The company provides analyzers for microscopy systems; and DIFF-Line, a hematology lab that handles a smaller amount daily blood samples, as well as consists of three instruments, such as CellaVision DC-1, RAL SmearBox, and RAL StainBox for smearing, staining, and analyzing peripheral blood smears. It also provides CellaVision DC-1 for performing blood cell differentials; and CellaVision DM1200 and Cella...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1994
• Employees: 241
• Stock Exchange: OTCMKTS
• Ticker Symbol: CLVSF

Financial Performance

In 2025, CellaVision AB's revenue was 758.97 million, an increase of 4.94% compared to the previous year's 723.22 million. Earnings were 153.08 million, an increase of 8.78%.

Financial numbers in SEK